The way of SARS-CoV-2 vaccine development: success and challenges

The way of SARS-CoV-2 vaccine development: success and challenges

Abstract Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of coronavirus disease 2019 (COVID-19). To halt the pandemic, multiple SARS-CoV-2 vaccines have been developed and several have been allowed for emergency use and rollout worldwide. With novel SARS-CoV-2 var...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yetian Dong, Tong Dai, Bin Wang, Lei Zhang, Ling-hui Zeng, Jun Huang, Haiyan Yan, Long Zhang, Fangfang Zhou
Formato: article
Lenguaje:EN
Publicado: Nature Publishing Group 2021
Materias:
Medicine
R
Biology (General)
QH301-705.5
Acceso en línea:https://doaj.org/article/b5e9d063126f4948b1f5c2cde8276777
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares